Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-06-27
2006-06-27
Chernyshev, Olga N. (Department: 1646)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S450000, C424S193100, C424S194100, C424S420000, C530S326000, C530S323000, C530S300000, C514S002600
Reexamination Certificate
active
07067133
ABSTRACT:
The present invention generally relates to the detection, treatment or prevention of disease states. Specifically, the present invention relates to the detection, treatment or prevention of amyloidosis or amyloid-associated diseases. The present invention further comprises methods and compositions comprising therapeutic vaccines, antisera and molecular constructs, comprising expression vectors and fusion proteins encoded therein.
REFERENCES:
patent: 6743427 (2004-06-01), Schenk
patent: 6787637 (2004-09-01), Schenk
patent: WO 99/27944 (1999-06-01), None
Walter et al., 1997, Biochem and Biophys Research Comm, 233, pp. 760-764.
Glenner, M.D., George G., et al., “Alzheimer's Disease: Initial Report of the Purification and Characterization of a Novel Cerebrovascular Amyloid Protein”, Biochemical and Biophysical Research Communications, vol. 120, No. 3, pp. 885-890 (1984).
Potter, Huntington, et al., “The Potential of BACE Inhibitors for Alzheimer's Therapy”, Nature Biotechnology, vol. 18, pp. 125-126 (2000).
Schenk, Dale, et al., “Immunization with Amyloid-β Attenuate Alzheimer-Disease-Like Pathology in the PDAPP Mouse”, Nature, vol. 400, pp. 173-177 (1999).
Solomon, Beka, et al., “Disaggregation of Alzheimer β-Amyloid by Site-Directed MAb”, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 4109-4112 (1997).
Tamaoka, Akira, et al., “Identification of a Stable Fragement of the Alzheimer Amyloid Precursor Containing the β-protein in Brain Microvessels”, Proc. Natl. Acad. Sci. USA, vol. 89, pp. 1345-1349 (1992).
Tosi, Pierre-François, et al., “Immune Response Against the Murine MDRI Protein Induced by Vaccination With Synthetic Lipopeptides in Liposomes”, Biochemical and Biophysical Research Communications, vol. 212, No. 2, pp. 494-500 (1995).
Aventis Pharma S.A.
Chernyshev Olga N.
Kilpatrick & Stockton LLP
Universite Louis Pasteur
LandOfFree
Methods and compositions for diseases associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for diseases associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for diseases associated with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3628717